Guidelines Development Group

The objective of the Guidelines Development Group (GDG) is to develop evidence-based European Guidelines for breast cancer screening and diagnosis for screening and diagnosis.

The GDG will follow the GRADE approach in defining the healthcare question of interest (population of interest, interventions to be compared and patient-relevant outcomes- PICO), synthesizing the evidence and developing the recommendations for the Guidelines. This will be carried out within virtual working environments and in meetings organised every three months.

An external contractor, CCIb –Iberoamerican Cochrane Centre, supports the GDG for their tasks from literature review to drafting of recommendations.

Members and external experts

Peter Rabe

Peter Rabe

Peter Rabe, born in 1979, is a business data processing specialist, working for the Mammography Cooperative a non-profit organization which maintains and evaluates the population based breast cancer screening program in Germany.

From 1998 to 2004 he studied business informatics at the University for Applied Sciences in Brandenburg, Germany. He started career as an assistant within the department for strategic supply management of Bavarian Association of Statutory Health Insurance Physicians in Munich. During this period he worked on establishing the Bavarian Mammography Screening, a regional breast cancer screening-project covering the whole federal state of Bavaria. Since 2006 he works for the Mammography Cooperative initially as assistant for evaluation later as consultant of the newly established department of IT and data management. Main focus of his work is to describe, develop and analyze IT- and software-solutions such as an ongoing catalog of specifications for documentation and data processing throughout the whole chain of screening and diagnostic activities. Therefore he is involved in several working groups targeting both professional and technical issues concerning mammography screening, such as a scientific advisory board for the evaluation of the screening based breast cancer mortality reduction or a national working group for an economic and standardized tumor documentation.

Declaration of interests